Tot Biopharm International Co Ltd

BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards

BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials

BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough

BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC

BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC